Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erbitux, Taxotere, and LDFRT in Recurrent Head and Neck Cancer
NCT01794845Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Jun 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140, docetaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by University of Miami. Started Jun 2013; status: terminated.
02
Drugs
KL-140docetaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01794845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794845.